APA

de Souza J. A., Saliba R. M., Patah P., Rondon G., Ribeiro R., de Padua Silva L., Qazilbash M. H., Hosing C., Popat U., Efebera Y., Champlin R. E. & de Lima M. (20091102). Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation. : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chicago

de Souza Jonas A, Saliba Rima M, Patah Poliana, Rondon Gabriela, Ribeiro Rachel, de Padua Silva Leandro, Qazilbash Muzaffar H, Hosing Chitra, Popat Uday, Efebera Yvonne, Champlin Richard E and de Lima Marcos. 20091102. Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation. : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Harvard

de Souza J. A., Saliba R. M., Patah P., Rondon G., Ribeiro R., de Padua Silva L., Qazilbash M. H., Hosing C., Popat U., Efebera Y., Champlin R. E. and de Lima M. (20091102). Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation. : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MLA

de Souza Jonas A, Saliba Rima M, Patah Poliana, Rondon Gabriela, Ribeiro Rachel, de Padua Silva Leandro, Qazilbash Muzaffar H, Hosing Chitra, Popat Uday, Efebera Yvonne, Champlin Richard E and de Lima Marcos. Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation. : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20091102.